AAV2-hFIX16

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAAV2-hFIX16
Drug Alias NameAAV2-hFIX16
ClassificationBiologics
Mechanisms of ActionBlood coagulation pathway activationCoagulation factor IX modulatorsFactor IX gene transference
TargetsCoagulation factor IX
Therapy Area/IndicationsHemophilia B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSpark Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSpark Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsHemophilia B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A